67 related articles for article (PubMed ID: 28864536)
1. Changes in the clinicopathological characteristics and genetic alterations of follicular thyroid cancer.
Song YS; Lim JA; Min HS; Kim MJ; Choi HS; Cho SW; Moon JH; Yi KH; Park DJ; Cho BY; Park YJ
Eur J Endocrinol; 2017 Dec; 177(6):465-473. PubMed ID: 28864536
[TBL] [Abstract][Full Text] [Related]
2. Selection Criteria for Completion Thyroidectomy in Follicular Thyroid Carcinoma Using Primary Tumor Size and TERT Promoter Mutational Status.
Park H; Heo J; Ki CS; Shin JH; Oh YL; Son YI; Kim JS; Kim SW; Chung JH; Kim TY; Kim TH; Kim JH
Ann Surg Oncol; 2023 May; 30(5):2916-2925. PubMed ID: 36637642
[TBL] [Abstract][Full Text] [Related]
3. RAS mutations in thyroid FNA specimens are highly predictive of predominantly low-risk follicular-pattern cancers.
Gupta N; Dasyam AK; Carty SE; Nikiforova MN; Ohori NP; Armstrong M; Yip L; LeBeau SO; McCoy KL; Coyne C; Stang MT; Johnson J; Ferris RL; Seethala R; Nikiforov YE; Hodak SP
J Clin Endocrinol Metab; 2013 May; 98(5):E914-22. PubMed ID: 23539734
[TBL] [Abstract][Full Text] [Related]
4. Association of Ultrasonography Features of Follicular Thyroid Carcinoma With Tumor Invasiveness and Prognosis Based on WHO Classification and TERT Promoter Mutation.
Kim MK; Park H; Oh YL; Shin JH; Kim TH; Hahn SY
Korean J Radiol; 2024 Jan; 25(1):103-112. PubMed ID: 38184773
[TBL] [Abstract][Full Text] [Related]
5. Spectrum of TERT promoter mutations and mechanisms of activation in thyroid cancer.
Panebianco F; Nikitski AV; Nikiforova MN; Nikiforov YE
Cancer Med; 2019 Oct; 8(13):5831-5839. PubMed ID: 31408918
[TBL] [Abstract][Full Text] [Related]
6. Role of hypermethylated SLC5A8 in follicular thyroid cancer diagnosis and prognosis prediction.
Yang Y; Liao C; Yang Q; Li Y; Tang Y; Xu B
World J Surg Oncol; 2023 Nov; 21(1):367. PubMed ID: 38007446
[TBL] [Abstract][Full Text] [Related]
7. TERT promoter mutations in thyroid cancer.
Matsuse M; Mitsutake N
Endocr J; 2023 Nov; 70(11):1035-1049. PubMed ID: 37532521
[TBL] [Abstract][Full Text] [Related]
8. Risk-stratified Distant Metastatic Thyroid Cancer with Clinicopathological Factors and BRAF/TERT Promoter Mutations.
Cheng X; Zhou Y; Xu S; Yu H; Wu J; Bao J; Zhang L
Exp Clin Endocrinol Diabetes; 2023 Nov; 131(11):577-582. PubMed ID: 37922948
[TBL] [Abstract][Full Text] [Related]
9. Age-associated mortality is partially mediated by TERT promoter mutation status in differentiated thyroid carcinoma.
Heo J; Lee S; Park J; Yang H; Park H; Ki CS; Oh YL; Kim HI; Kim SW; Chung JH; Kim K; Kim TH
PLoS One; 2023; 18(11):e0294145. PubMed ID: 37948420
[TBL] [Abstract][Full Text] [Related]
10. Role of the Degree of Vascular Invasion in Predicting Prognosis of Follicular Thyroid Carcinoma.
Yamazaki H; Sugino K; Katoh R; Matsuzu K; Kitagawa W; Nagahama M; Rino Y; Saito A; Ito K
J Clin Endocrinol Metab; 2024 Apr; 109(5):1291-1300. PubMed ID: 38006314
[TBL] [Abstract][Full Text] [Related]
11. Circulating small extracellular vesicle-based miRNA classifier for follicular thyroid carcinoma: a diagnostic study.
Li G; Wang H; Zhong J; Bai Y; Chen W; Jiang K; Huang J; Shao Y; Liu J; Gong Y; Zhang J; Sun R; Wei T; Gong R; Zhu J; Lu Z; Li Z; Lei J
Br J Cancer; 2024 Apr; 130(6):925-933. PubMed ID: 38238428
[TBL] [Abstract][Full Text] [Related]
12. Letter to Editor in Response to Article Entitled "Selection Criteria for Completion Thyroidectomy in Follicular Thyroid Carcinoma Using Primary Tumor Size and TERT Promotor Mutational Status".
Park H; Kim TY; Kim TH; Kim JH
Ann Surg Oncol; 2023 Dec; 30(13):8546-8547. PubMed ID: 37789109
[No Abstract] [Full Text] [Related]
13. Letter to the Editor in Response to the Article Entitled "Selection Criteria for Completion Thyroidectomy in Follicular Thyroid Carcinoma Using Primary Tumor Size and TERT Promotor Mutational Status".
Behra DP; Mishra A
Ann Surg Oncol; 2023 Dec; 30(13):8545. PubMed ID: 37751118
[No Abstract] [Full Text] [Related]
14. Unmasking the Silent Invader: A Rare Case of Follicular Thyroid Carcinoma With Skull Metastasis and an Uncommon KRAS Q61R Mutation.
Huang HH; Ji P; Peng SK
Cureus; 2023 Oct; 15(10):e47641. PubMed ID: 38021925
[TBL] [Abstract][Full Text] [Related]
15. Protocol of a thyroid cancer longitudinal study (T-CALOS): a prospective, clinical and epidemiological study in Korea.
Lee KE; Park YJ; Cho B; Hwang Y; Choi JY; Kim SJ; Choi H; Choi HC; An AR; Park DJ; Park SK; Youn YK
BMJ Open; 2015 Jan; 5(1):e007234. PubMed ID: 25564151
[TBL] [Abstract][Full Text] [Related]
16. Influencers on Thyroid Cancer Onset: Molecular Genetic Basis.
Luzón-Toro B; Fernández RM; Villalba-Benito L; Torroglosa A; Antiñolo G; Borrego S
Genes (Basel); 2019 Nov; 10(11):. PubMed ID: 31717449
[TBL] [Abstract][Full Text] [Related]
17. Role of molecular markers to predict distant metastasis in papillary thyroid carcinoma: Promising value of TERT promoter mutations and insignificant role of BRAF mutations-a meta-analysis.
Vuong HG; Altibi AM; Duong UN; Ngo HT; Pham TQ; Tran HM; Oishi N; Mochizuki K; Nakazawa T; Hassell L; Katoh R; Kondo T
Tumour Biol; 2017 Oct; 39(10):1010428317713913. PubMed ID: 29037127
[TBL] [Abstract][Full Text] [Related]
18. Pre-operative features of non-invasive follicular thyroid neoplasms with papillary-like nuclear features: An analysis of their cytological, Gene Expression Classifier and sonographic findings.
Song SJ; LiVolsi VA; Montone K; Baloch Z
Cytopathology; 2017 Dec; 28(6):488-494. PubMed ID: 29165886
[TBL] [Abstract][Full Text] [Related]
19. Reintroducing the Sodium-Iodide Symporter to Anaplastic Thyroid Carcinoma.
Schmohl KA; Dolp P; Schug C; Knoop K; Klutz K; Schwenk N; Bartenstein P; Nelson PJ; Ogris M; Wagner E; Spitzweg C
Thyroid; 2017 Dec; 27(12):1534-1543. PubMed ID: 29032724
[TBL] [Abstract][Full Text] [Related]
20. Low frequency of TERT promoter mutations in a series of well-differentiated follicular-patterned thyroid neoplasms.
Proietti A; Sartori C; Macerola E; Borrelli N; Materazzi G; Vitti P; Basolo F
Virchows Arch; 2017 Dec; 471(6):769-773. PubMed ID: 28975450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
